LONSURF Dosing Calculator

Calculate Your LONSURF Dose

cm
kg
Standard starting dose is 35 mg/m² twice daily. Adjustments may be necessary based on toxicity or impairment.
Moderate renal impairment may require a dose reduction to 20 mg/m² BID. Severe impairment is generally not recommended.
No specific initial dose adjustment for mild/moderate hepatic impairment. Severe impairment not studied.

LONSURF Dosing Guideline Table

Example LONSURF Dosing by Body Surface Area (BSA) - Standard 35 mg/m² BID
BSA (m²) Target Dose per Admin (mg) Tablet Combination (15mg/20mg) Total Daily Dose (mg)

LONSURF Dose vs. Body Weight Chart

LONSURF Dose per Administration (Trifluridine) based on Body Weight for a fixed height (170 cm / 67 inches).

What is LONSURF Dosing?

The LONSURF dosing calculator is an essential tool for healthcare professionals and patients to accurately determine the appropriate dosage of LONSURF (trifluridine/tipiracil). LONSURF is an oral anticancer medication used in the treatment of metastatic colorectal cancer and metastatic gastric or gastroesophageal junction adenocarcinoma. Accurate dosing is critical to maximize therapeutic efficacy while managing potential side effects. The dosage is primarily determined by the patient's Body Surface Area (BSA), which is calculated from their height and weight.

Who should use a LONSURF dosing calculator? This tool is primarily for oncologists, pharmacists, and other medical professionals involved in prescribing and dispensing LONSURF. Patients may also use it for informational purposes to understand their prescribed dosage, but they should always consult their healthcare provider for medical advice and final dosing decisions. Common misunderstandings often arise regarding the units used for height and weight (e.g., mixing imperial and metric systems) or misinterpreting dose adjustments for organ impairment or toxicity, highlighting the need for a precise tool.

LONSURF Dosing Formula and Explanation

The standard recommended starting dosage of LONSURF is 35 mg/m² (based on the trifluridine component) orally twice daily (BID) on Days 1-5 and Days 8-12 of each 28-day cycle. The calculation involves two main steps:

1. Body Surface Area (BSA) Calculation

BSA is a measure of the surface area of a human body. The Mosteller formula is widely used for this calculation:

  • If Height in cm and Weight in kg:
    BSA (m²) = √((Height in cm × Weight in kg) / 3600)
  • If Height in inches and Weight in lbs:
    BSA (m²) = √((Height in inches × Weight in lbs) / 3131)

Once BSA is determined, it forms the basis for the LONSURF dose.

2. LONSURF Dose Calculation

The dose is then calculated based on the BSA and the target dose per square meter.

  • LONSURF Dose per Administration (mg, Trifluridine) = BSA (m²) × Target Dose per m² (mg/m²)
  • Total Daily LONSURF Dose (mg, Trifluridine) = LONSURF Dose per Administration × 2 (since it's twice daily)
  • Total LONSURF Dose per Cycle (mg, Trifluridine) = Total Daily LONSURF Dose × 10 (for 10 days of administration per 28-day cycle)

The calculated dose per administration must then be achieved using available LONSURF tablet strengths (15 mg and 20 mg trifluridine). Doses are typically rounded to the nearest 5 mg increment that can be achieved with these tablets.

Variables Table

Key Variables for LONSURF Dosing
Variable Meaning Unit Typical Range
Height Patient's height cm or inches 140-190 cm (55-75 in)
Weight Patient's weight kg or lbs 40-100 kg (88-220 lbs)
BSA Body Surface Area 1.2-2.5 m²
Target Dose per m² Prescribed LONSURF dose per square meter mg/m² 20-35 mg/m²
Dose per Admin LONSURF dose for a single administration mg 30-80 mg
Total Daily Dose Total LONSURF dose taken in one day mg 60-160 mg
Total Cycle Dose Total LONSURF dose taken over a 28-day cycle mg 600-1600 mg

Practical Examples of LONSURF Dosing

Example 1: Standard Dosing

A 65-year-old male patient with metastatic colorectal cancer:

  • Inputs:
    • Height: 175 cm
    • Weight: 75 kg
    • Target Dose per m²: 35 mg/m²
    • Renal/Hepatic Impairment: None/Mild
  • Calculations:
    • BSA = √((175 × 75) / 3600) ≈ 1.89 m²
    • Target Dose per Admin = 1.89 m² × 35 mg/m² = 66.15 mg
    • Rounded Dose per Admin (closest tablet combination): 65 mg (e.g., 1x 20mg + 3x 15mg or 3x 20mg + 1x 15mg)
    • Total Daily Dose = 65 mg × 2 = 130 mg
    • Total Cycle Dose = 130 mg × 10 days = 1300 mg
  • Results: Recommended LONSURF Dose per Administration: 65 mg.

Example 2: Dosing with Unit Conversion and Adjustment Consideration

A 70-year-old female patient:

  • Inputs:
    • Height: 5 feet 4 inches (64 inches)
    • Weight: 140 lbs
    • Target Dose per m²: 35 mg/m² (initially)
    • Renal Impairment: Moderate (CrCl 30-59 mL/min)
    • Hepatic Impairment: None/Mild
  • Calculations:
    • BSA = √((64 × 140) / 3131) ≈ 1.69 m²
    • Initial Target Dose per Admin = 1.69 m² × 35 mg/m² = 59.15 mg
    • *However, due to moderate renal impairment, a dose reduction to 20 mg/m² BID is often recommended.*
    • Adjusted Target Dose per Admin = 1.69 m² × 20 mg/m² = 33.8 mg
    • Rounded Dose per Admin (closest tablet combination): 35 mg (e.g., 1x 15mg + 1x 20mg)
    • Total Daily Dose = 35 mg × 2 = 70 mg
    • Total Cycle Dose = 70 mg × 10 days = 700 mg
  • Results: Recommended LONSURF Dose per Administration: 35 mg, considering renal impairment adjustment. This example highlights how units (inches/lbs converted internally) and clinical factors influence the final dose.

How to Use This LONSURF Dosing Calculator

  1. Enter Patient Height: Input the patient's height in either centimeters (cm) or inches. Use the adjacent dropdown to switch between units.
  2. Enter Patient Weight: Input the patient's weight in either kilograms (kg) or pounds (lbs). Use the adjacent dropdown to switch between units.
  3. Set Target LONSURF Dose per m²: The default is 35 mg/m², which is the standard starting dose. This can be adjusted by the healthcare provider based on clinical factors, toxicity, or specific guidelines (e.g., dose reductions for renal impairment).
  4. Select Renal and Hepatic Impairment Status: Choose the appropriate options. While these selections don't automatically alter the primary calculated dose in this tool (as adjustments are complex and physician-dependent), they provide important context in the result explanation regarding potential dose modifications.
  5. Click "Calculate Dose": The calculator will instantly display the results.
  6. Interpret Results:
    • Primary Result: The recommended LONSURF Dose per Administration (mg) and the suggested tablet combination (e.g., 20mg, 15mg tablets) will be prominently displayed. This is the amount of trifluridine the patient should take twice daily.
    • Body Surface Area (BSA): The calculated BSA in m².
    • Target Dose per Administration: The precise calculated dose before rounding to tablet combinations.
    • Total Daily LONSURF Dose: The total amount of trifluridine taken per day.
    • Total LONSURF Dose per Cycle: The total amount of trifluridine taken over the 10-day administration period within a 28-day cycle.
  7. Use the "Copy Results" Button: Easily copy all results and explanations for documentation.
  8. Use the "Reset" Button: Clear all inputs and restore default values.

Always verify calculations with official prescribing information and clinical judgment. This calculator is for informational and educational purposes only and should not replace professional medical advice.

Key Factors That Affect LONSURF Dosing

Several factors influence the appropriate LONSURF dosage, making a personalized chemotherapy dosing strategy essential:

  • Body Surface Area (BSA): As the primary determinant, BSA ensures that the dose is proportional to the patient's body size. Changes in height or weight will directly impact BSA and, consequently, the dose.
  • Renal Function (Kidney Impairment): Patients with moderate renal impairment (CrCl 30-59 mL/min) typically require a dose reduction to 20 mg/m² BID. LONSURF is not recommended for severe renal impairment (CrCl < 30 mL/min) due to increased exposure and potential toxicity.
  • Hepatic Function (Liver Impairment): No specific dose adjustment is recommended for patients with mild to moderate hepatic impairment. Severe hepatic impairment has not been studied.
  • Adverse Reactions/Toxicity: The most significant factor for dose adjustments after initiation is the occurrence of adverse events, particularly hematologic toxicities (e.g., neutropenia, thrombocytopenia) and non-hematologic toxicities (e.g., severe diarrhea, nausea, vomiting). Doses may be reduced or interrupted based on the severity and duration of these toxicities.
  • Concomitant Medications: Interactions with other drugs can affect LONSURF metabolism or increase toxicity, potentially necessitating dose adjustments.
  • Patient Performance Status: A patient's general health and ability to perform daily activities (e.g., ECOG performance status) can influence the physician's decision regarding the tolerability of a particular dose.
  • Disease Progression: While not directly affecting the dose calculation, if the disease progresses on a certain dose, the treatment strategy, including dose or drug choice, may be re-evaluated.

Frequently Asked Questions about LONSURF Dosing

Q1: Why is BSA used for LONSURF dosing?

A: BSA is used because it provides a more consistent measure of metabolic mass and drug distribution than weight alone, especially for chemotherapy drugs, helping to normalize drug exposure across different body sizes.

Q2: Can I use pounds and inches in the calculator?

A: Yes, our BSA calculator component allows you to switch between metric (cm, kg) and imperial (inches, lbs) units. The calculator will automatically convert values internally for accurate BSA calculation.

Q3: What if the calculated dose isn't an exact tablet strength?

A: LONSURF is available in 15 mg and 20 mg trifluridine tablets. Doses are typically rounded to the nearest 5 mg increment that can be achieved by combining these tablets. Our calculator provides the nearest achievable dose and suggests a tablet combination.

Q4: Does renal or hepatic impairment automatically adjust the dose in this calculator?

A: This calculator provides the standard BSA-based dose. While you can select impairment status, it primarily serves as a reminder for potential adjustments. Actual dose adjustments for renal or hepatic impairment, or for toxicity, are complex and must be made by a healthcare professional based on specific clinical guidelines and patient assessment.

Q5: What are the LONSURF tablet strengths?

A: LONSURF is available as film-coated tablets containing 15 mg trifluridine and 6.14 mg tipiracil, or 20 mg trifluridine and 8.19 mg tipiracil. The dose is always expressed in terms of the trifluridine component.

Q6: How many days is LONSURF typically administered per cycle?

A: LONSURF is typically administered orally twice daily on Days 1-5 and Days 8-12 of each 28-day cycle, for a total of 10 days of administration per cycle.

Q7: Can LONSURF be given once daily?

A: No, the recommended dosing regimen for LONSURF is twice daily (BID) to maintain therapeutic drug levels and optimize efficacy.

Q8: What should I do if I suspect a dosing error?

A: If you are a patient, contact your healthcare provider immediately. If you are a healthcare professional, double-check all calculations and consult with a pharmacist or senior clinician. Always refer to the official LONSURF prescribing information.

Explore our other valuable resources and calculators related to oncology and patient care:

🔗 Related Calculators